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Investigating the causal relationship of C-reactive protein with 32 complex somatic and 
psychiatric outcomes: A large scale cross-consortia Mendelian randomization study. 
 
S1 Figure. GRS P Plots of CRP versus each outcome 
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For each disease / trait we show the plots for two genetic risk scores ; on the left the GRSCRP and on the right 
GRSGWAS. For every graph, the estimated effects on disease risk (log odds) or trait level (vertical axis) are plotted 
against estimated effects on the natural log CRP levels (mg/ml) (horizontal axis), for either the GRSCRP SNPs or 
GRSGWAS SNPs that are associated with CRP levels. The grey vertical lines indicate the 95% confidence interval 
(CI) for each individual SNP. The effect estimate estimate of CRP levels on disease risk or trait level is 
represented by a red solid line with gradient α. The 95% CI of this α estimate is represented by red dashed lines. 
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Investigating the causal relationship of C-reactive protein with 32 complex 
somatic and psychiatric outcomes: A large scale cross-consortia Mendelian 
randomization study. 
 
Supplementary Methods 1:  Linkage disequilibrium of the four GRSCRP SNPs. 
 
Methods: The figure was generated using Haploview. LD values (r
2
) were calculated 
using Hapmap Phase II+III (r28, CEU population) data. r
2
 values are shown between 
SNPs pairs on a scale between 0 (no LD) to 100 (full LD) in diamonds colored on a 
corresponding grayscale, where no LD is represented by white and full LD by black. This 
plot indicates low LD between each of the four SNPs spanning the CRP gene. 
 
S2 Fig: Linkage disequilibrium (LD) heatplot for 4 SNPs as used in the GRSCRP IV. 
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Investigating the causal relationship of C-reactive protein with 32 complex 
somatic and psychiatric outcomes: A large scale cross-consortia Mendelian 
randomization study. 
 
Supplementary Methods - 2: CRP GRSGWAS in AD and BMI. 
 
A. Calculation of the Alzheimer’s Disease GWAS summary statistics. 
We received summary statistics (SNP, OR, SE, P, Reference Allele, Other Allele, OR 95 L ,OR 95 U) from the 
Genetic and Environmental Risk in Alzheimer's Disease (GERAD) consortium for three separate 
Alzheimer’s datasets ; from the TGEN consortium, from the ADNI consortium, and from the GERAD 
consortium for up to 4,663 cases and 8,357 controls. We next performed an inverse variance weighted 
fixed effects analysis using GWAMA1 to calculate combined effect sizes and standard errors, which were 
subsequently used in our genetic risk scores. 
B. Calculation of the BMI GWAS summary statistics. 
We downloaded sex-stratified summary statistics for BMI from Randall et.al 2. From 
https://www.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files. We 
next performed an inverse variance weighted fixed effects analysis using GWAMA1 to calculate combined 
effect sizes and standard errors, which were subsequently used in our genetic risk scores.  
1 Mägi R, Morris AP. GWAMA: software for genome-wide association meta-analysis. BMC Bioinformatics. 
2010 May 28;11:288.  
2 Randall JC. Sex-stratified genome-wide association studies including 270,000 individuals show sexual 
dimorphism in genetic loci for anthropometric traits. PLoS Genet. 2013 Jun;9(6):e1003500. 
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Investigating the causal relationship of C-reactive protein with 32 complex 
somatic and psychiatric outcomes: A large scale cross-consortia Mendelian 
randomization study. 
Supplementary Methods - 3: WEBLINKS. 
 
Software :  
Genetics ToolboX (version 0.0.8):  
 http://cran.r-project.org/web/packages/gtx/index.html 
Functions for Medical Statistics Book with some Demographic Data 
https://cran.r-project.org/web/packages/fmsb/ 
http://www.genemania.org 
Publicly downloaded GWAS summary statistics:  
1. GIANT BMI summary statistics:  
www.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files 
2. CARDIoGRAM CAD summary statistics:  
www.cardiogramplusc4d.org 
3. Rheumatoid arthritis summary statistics:  
www.broadinstitute.org/ftp/pub/rheumatoid arthritis/Stahl_etal_2010NG/ 
4. PGC consortium (psychiatric) summary statistics:  
www.med.unc.edu/pgc/downloads 
5. Systemic Lupus Erythematosus 
Data was downloaded through dbGaP : http://www.ncbi.nlm.nih.gov/gap 
Study name : Whole Genome Association Study of Systemic Lupus Erythematosus  
dbGaP Study Accession: phs000122.v1.p1  
Analysis Name and Accession 
Name: Whole Genome Association Study of Systemic Lupus Erythematosus  
Accession: pha002848.1 
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Investigating the causal relationship of C-reactive protein with 32 complex 
somatic and psychiatric outcomes: A large scale cross-consortia Mendelian 
randomization study. 
Supplementary Methods - 4: CRP Polygenic risk score (CRPPRS) in Schizophrenia. 
                                                                                                                  
Background: We observed a causally protective effect of CRP GWSAs against Schizophrenia. We 
aim to determine whether a) CRP-associated risk alleles are associated with schizophrenia by 
employing the use of polygenic risk scores, and b) to determine if the relationship between CRP 
and schizophrenia is due to genetic pleiotropy or clinical heterogeneity. Here below we explain 
study design and applied methods. 
Sample Description: Individual-level dosage data was retrieved from the Psychiatric Genomics 
Consortium (PGC) Schizophrenia dataset, consisting of 36 independent cohorts with a combined 
25629 cases and 30976 controls. 3 family-based samples of European ancestry (1,235 parent 
affected-offspring trios) were excluded from our analysis. For a more detailed treatment of the 
PGC schizophrenia dataset, refer to the methods section of the full paper (Ripke et al., 2014). 
Selection of CRP-associated SNPs : Summary statistics (including SNP RSID, chromosome and 
position, coded allele, beta, standard error, and p value) were retrieved from a meta-analysis of 
15 independent European population-based studies with 66,185 participants (Dehghan et al., 
2011). After accounting for the replication sample, 18 SNPs reached genome-wide significance 
(p < 5 x 108) and were thus included in the study.  All non-genome-wide significant SNPs were 
clumped based on linkage disequilibrium estimates using plink v2 with the following flags: --
clump-p1 1 –clump-p2 1 –clump-r2 0.1 –clump-kb 1000. Thus, all SNPs included in the analyses 
were LD-independent, as defined by SNPs with r2 < 0.1 (Purcell et al., 2007). We subsequently 
grouped the sub-threshold CRP-associated SNPs at the following p-value thresholds: 1x10-4, 
0.001, 0.01, 0.05, and 0.1.  
Statistical Analysis: Polygenic risk scores were calculated for each individual by summing the 
total effect of the SNP dosages by its effect size. This was performed for each independent 
schizophrenia cohort using plink v2 with the –score and –qscore flags (Purcell et al., 2007). A 
fixed effects, inverse variance weighted meta-analysis was performed across all 36 cohorts 
using a custom R script. Briefly, beta estimates (log odds ratios) was weighted by the estimated 
standard errors. 10 PCs were regressed out of each independent cohort to account for 
population stratification.  
Results 
Examining the association between the 18 CRP-associated risk alleles in GWAS and 
schizophrenia 
13 out of the 18 SNPs associated with elevated CRP levels were protective against schizophrenia 
(Fig 1, and S3 Fig). Five out of the 13 SNPs reached a significance threshold of p < 0.05 (S3 Fig). 
A sign test was performed to determine if the risk alleles for CRP are shared with schizophrenia 
more than expected (P<0.096). 
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S3 Fig: 18 risk alleles associated with elevated CRP levels that reached genome-
wide significance, and their corresponding schizophrenia odds ratios. 
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Supplementary Methods - 5: In-silico (gene) pathway analyses highlight the role 
of IFN in the causal pathway between CRP and SCZ. 
 
Background: We aimed to explore the possible underlying pathways that may underwrite the 
protective causal association between CRP and schizophrenia. We answered this question by 
performing two studies: In the first study we aimed to elucidate through which potential 
pathways CRP associated proteins (encoded by those genes which are tagged by CRP associated 
gSNPs and eSNPs potentially are linked to genes associated to SCZ, more specifically, those that 
are differentially expressed in schizophrenia cases versus controls  
Study I : Identification of common pathways between genes / their encoded proteins involved in 
determination on CRP levels and proteins differentially expressed in schizophrenia cases versus 
controls.  
The following 3 steps were taken: 
1.1) We firstly retrieved a list of CRP-associated genes whom harboured by loci associated with 
CRP in the large GWAS meta-analysis for CRP to date [6] and genes for which their expression 
was associated with one or more of the above mentioned 18 loci as presented by Vaez et.al.[7]. 
These groups of genes and their selection processes have been discussed in greater detail in our 
previous publication by Vaez et.al.[7] and presented in Table 2 of the respective paper and for 
convenience listed again in our S4 Table (tabname “CRP genes”). We used the 40 CRP genes 
from Table 2 in Vaez et. al. [7] and performed enrichment analyses as explained in the same 
publication [7] using the well-established pathway and network analysis suite Genemania (S3 
Methods Weblinks) [8], the result of which is presented in S Table 6 (tabname “S6. CRP enriched 
pathways”). As previously observed[7] the most enriched functions within this geneset are 
related to the type I interferon signaling pathway (FDR=6.08x10-9). 
 
1.2) Secondly, we retrieved a list of 144 proteins, which are significantly differentially expressed 
in brain tissues of schizophrenia cases compared with matched controls, hence are expected to 
be involved in the mechanism of schizophrenia. These proteins are presented in the study by 
Hwang et.al. [9] in their respective S Table 4. These proteins are listed in our S6 Table (tabname 
“SCZ expr genes”). We performed functional enrichment analysis for this geneset in the same 
fashion as described above, the results of which are presented in S7 Table (tabname “SCZ expr 
enriched pathways”). 
None of the differentially expressed proteins from the study of Hwang et.al overlap. with 
proteins encoded by genes identified by Vaez et.al. except the HEYL, which is a non-
inflammatory gene. Surprisingly, we observed that the most significantly enriched function for 
the set of differentially expressed proteins is also the type I interferon signalling pathway 
(FDR=2.81x10-12) . 
 
1.3) Lastly, to confirm the type I interferon signalling pathway may be the predominant 
pathway that is shared between these two sets of proteins, we performed functional prediction 
and pathway enrichment analyses by including all the 40 CRP associated and 144 SCZ 
associated genes as presented S8 Table (tabname “CRP & SCZ expr gene list”), the results of 
which are presented in S9 Table (tabname “CRP&SCZ enriched pathways”). We observed again 
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that the type I interferon signalling pathway remained as the most significantly enriched 
pathway (FDR=8.60x10-22). 
Summary of study 1 : Identification of common pathways between genes / their encoded proteins 
involved in determination on CRP levels and proteins differentially expressed in schizophrenia 
cases versus controls.  
Our in-silico functional enrichment analysis from both CRP and SCZ associated genes showed 
the enrichment of pathways of “response to type I interferon”, “cellular response to type I 
interferon”, “type I interferon signaling pathway”.  
We therefore speculate the protective causal effect of CRP might be explained by the fact 
that T-cell IFN cytokine release stimulates microglia to facilitate glutamate clearance in 
neuronal cells without evoking inflammatory mediators, and by contributing to restoration of 
normal homeostasis[1,2]. 
Study 2 : Identification of pathways involved in schizophrenia based on loci identified in the largest 
Genome Wide Association Study for schizophrenia and their associated eQTLs in brain and blood, 
excluding any known CRP associated genes and associated eQTLs. 
Our second study intended to investigate through which pathways do non-CRP SCZ associated 
genes and their encoded proteins affect SCZ. We took a similar approach to our first study, 
where now instead we use the results from the largest meta-GWAS study for schizophrenia[10] 
as a basis as follows :  
2.1) Firstly, we extracted the list of genes harboured by 108 SCZ associated loci at genome wide 
significance level from the largest meta-GWAs in SCZ published by the Schizophrenia Working 
Group of the Psychiatric Genomics Consortium, as listed in S Table 3 in the respective study[10] 
and in our S10 Table (tabname “SCZ 108 loci genes”). 
2.2) Next we extracted all genes tagged by expression quantitative trait loci (eQTL) from a 
human brain cortex eQTL study and another eQTL study performed in peripheral blood cells as 
listed in S Table 4 in the same publication [10], and in our S11 Table (tabname “SCZ 108 loci 
eQTL”) and merged these with the list of genes harboured by 108 SCZ associated loci mentioned 
above. We removed duplicate genes and to focus on non-CRP associated pathways, we 
additionally removed genes overlapping with those from Vaez et. al., resulting in the removal of 
in total, C12orf42). The combined set of genes is presented in S12 Table (tabname “SCZ eQTL + 
108 loci genes”). 
2.3) We performed the same functional enrichment analyses as explained earlier on this 
combined set of 407 genes. The (non-)results are presented in S13 Table (tabname “eQTL&SCZ 
loci enr pathways”).  
 
Summary of Study 2 : Identification of pathways involved in schizophrenia based on loci identified 
in the largest Genome Wide Association Study for schizophrenia and their associated eQTLs in 
brain and blood, excluding any known CRP associated genes and associated eQTLs. 
Similar to the main manuscript, we failed to identify any significantly enriched pathways, in our 
case using Genemania, although nominally significantly enrichments were observed for several 
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predefined candidate pathways such as calcium channels in the original publication. In our case 
we included also eQTL loci whereas the original study used the meta-analysis summary 
statistics. We did not identify any inflammatory related pathways these analyses. The report 
from the Schizophrenia Working Group of the Psychiatric Genomics Consortium does however 
provide some evidence for a role of the immune system in schizophrenia development when 
searching for the most relevant cell-types based on their genomic loci and cell and tissue type 
specific enhancers enrichment analyses ; two peaks can be observed in Fig 2 for B-lymphocyte 
lineages involved in acquired immunity (CD19 and CD20 cell lines), which remained significant 
even after excluding the extended MHC region and regions containing brain enhancers[10]. The 
main original study has not report any significantly enriched pathway, and neither did our 
analyses led to such a conclusion based on the presented data in [10] .  
Taken together, our in-silico analyses point to a role for pathway associated to IFN 
response and metabolism that may possibly underlie protective effect of CRP in schizophrenia. 
Specifically, we speculate that CRP-IFN pathway perhaps contributes to neuroprotection by 
stimulating a phenotype in neuron supporting cells such as astrocytes or microglia that 
facilitates glutamate reduction as observed directly for IFN by Shaked et.al [2] and Garg et.al [1] 
leading to the protection of neurons against oxidative stress associated with an excess of 
glutamate. 
Associated files: 
Please find lists of trait-associated genes and results of pathway enrichment analyses in S4 
Table to S13 Table. The first tab in this file, named as “Contents” contains a guide to the contents 
of this file.  
Web link: http://www.genemania.org 
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